ACE Biolabs is devoted to provide the most comprehensive “one-stop laboratory services”, including gene synthesis, protein expression, antibody production, virus package and cell line generation. The number of cases of COVID-19 (SARS-CoV-2; 2019-nCoV) virus infections in China and worldwide is rising dramatically. Reliable diagnoses on a large scale are increasingly needed. ACE Biolabs is actively in the process of developing COVID-19 (SARS-CoV-2; 2019-nCoV) virus related products for providing raw materials of diagnostic detection kit, antibody production, and viral research. Moreover, ACE Biolabs releases our own special design of immunologic adjuvant to speed up anti-2019-nCoV antibody development process. ACE Biolabs is willing to contribute our strengths for defeating COVID-19 (SARS-CoV-2; 2019-nCoV) virus epidemic.
Until now, ACE Biolabs successful established several COVID-19 (SARS-CoV-2; 2019-nCoV) virus related products, including:
Proteins: Nucleocapsid Protein, Spike protein and Spike-RBD protein
Antibody: Anti-NP (SARS-CoV-2) antibody, Anti-S (SARS-CoV-2) antibody
Pseudovirus: as a Quality control for RNA extraction and virus detection using qPCR; or for Neutralization Assay
Potent compounds for virus inhibition: Remdesivir and its intermediate.
| Catalog# | Name |
|---|---|
| A27334PI | ACE2 Polyclonal Antibody |
| CL0021 | ACE2-3xFLAG-HEK293T stable cell line |
| P0051 | Recombinant Human ACE2 protein, His Tag |
With the now global outbreak of COVID-19, SARS-CoV-2 early diagnostics and infection prevention and control has become critical. ACE Biolabs can provide the following products lines for SARS-CoV-2 (2019-nCoV, COVID-19 virus) research:
.png)